Cargando…

Testing Fmr1(KO) Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127

Glycogen synthase kinase 3 (GSK3) is a proline-directed serine-threonine kinase that is associated with several neurological disorders, including Alzheimer’s disease and fragile X syndrome (FXS). We tested the efficacy of a novel GSK3 inhibitor AFC03127, which was developed by Angelini Pharma, in co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westmark, Pamela R., Garrone, Beatrice, Ombrato, Rosella, Milanese, Claudio, Di Giorgio, Francesco Paolo, Westmark, Cara J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529056/ https://www.ncbi.nlm.nih.gov/pubmed/34690696 http://dx.doi.org/10.3389/fnmol.2021.751307

Ejemplares similares

Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1(KO) Mice
por: Westmark, Cara J., et al.
Publicado: (2011)

Glycogen Synthase Kinase 3 (GSK3) Inhibitor, SB-216763, Promotes Pluripotency in Mouse Embryonic Stem Cells
por: Kirby, Leslie A., et al.
Publicado: (2012)

SB‐216763, a GSK‐3β inhibitor, protects against aldosterone‐induced cardiac, and renal injury by activating autophagy
por: Zhang, Yi‐De, et al.
Publicado: (2018)

Comparative Behavioral Phenotypes of Fmr1 KO, Fxr2 Het, and Fmr1 KO/Fxr2 Het Mice
por: Saré, Rachel Michelle, et al.
Publicado: (2019)

Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction
por: Westmark, Cara J., et al.
Publicado: (2020)

Effects of Soy-Based Infant Formula on Obesity and Neurodevelopment in an Autism Mouse Model
por: Westmark, Cara, et al.
Publicado: (2022)

Sustained release of a highly specific GSK3β inhibitor SB216763 in the PCL scaffold creates an osteogenic niche for osteogenesis, anti-adipogenesis, and potential angiogenesis
por: Gong, Weimin, et al.
Publicado: (2023)

Small-Molecule SB216763-Loaded Microspheres Repair Peripheral Nerve Injury in Small Gap Tubulization
por: Rao, Feng, et al.
Publicado: (2019)

Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
por: Zhang, Jing, et al.
Publicado: (2020)

Soy Infant Formula and Seizures in Children with Autism: A Retrospective Study
por: Westmark, Cara J.
Publicado: (2014)

A Hypothesis Regarding the Molecular Mechanism Underlying Dietary Soy-Induced Effects on Seizure Propensity
por: Westmark, Cara Jean
Publicado: (2014)

Soy Infant Formula may be Associated with Autistic Behaviors
por: Westmark, Cara J.
Publicado: (2013)

Commentary: Depletion of the Fragile X Mental Retardation Protein in Embryonic Stem Cells Alters the Kinetics of Neurogenesis
por: Westmark, Cara J.
Publicado: (2017)

FMRP: a triple threat to PSD-95
por: Westmark, Cara J.
Publicado: (2013)

Soy-Based Therapeutic Baby Formulas: Testable Hypotheses Regarding the Pros and Cons
por: Westmark, Cara J.
Publicado: (2017)

Diet in the Treatment of Epilepsy
por: Westmark, Cara J.
Publicado: (2021)

Parental Reports on Early Autism Behaviors in Their Children with Fragile X Syndrome as a Function of Infant Feeding
por: Westmark, Cara J.
Publicado: (2021)

Consumption of Breast Milk Is Associated with Decreased Prevalence of Autism in Fragile X Syndrome
por: Westmark, Cara J.
Publicado: (2021)

Ketogenic Diet Affects Sleep Architecture in C57BL/6J Wild Type and Fragile X Mice
por: Westmark, Pamela R., et al.
Publicado: (2023)

Corrigendum: Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
Publicado: (2021)

Effects of Soy-Based Infant Formula on Weight Gain and Neurodevelopment in an Autism Mouse Model
por: Westmark, Cara J., et al.
Publicado: (2022)

FMRP Mediates mGluR(5)-Dependent Translation of Amyloid Precursor Protein
por: Westmark, Cara J, et al.
Publicado: (2007)

Fmr1 KO Mice as a Possible Model of Autistic Features
por: Bernardet, Maude, et al.
Publicado: (2006)

Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice
por: Ma, Xian-Cang, et al.
Publicado: (2013)

Reply to “The Fallacy of Using Administrative Data in Assessing the Effectiveness of Food Fortification. Comment on: Folic Acid Fortification and Neural Tube Defect Risk: Analysis of the Food Fortification Initiative Dataset. Nutrients 2020, 12, 247”
por: Westmark, Cara J., et al.
Publicado: (2020)

Folic Acid Fortification and Neural Tube Defect Risk: Analysis of the Food Fortification Initiative Dataset
por: Murphy, Michaela E., et al.
Publicado: (2020)

Homeostatic Intrinsic Plasticity Is Functionally Altered in Fmr1 KO Cortical Neurons
por: Bülow, Pernille, et al.
Publicado: (2019)

Enhancement of Glycosaminoglycan-Rich Matrix Production in Human Marrow-Derived Mesenchymal Stem Cell Chondrogenic Culture by Lithium Chloride and SB216763 Treatment
por: Baghaban Eslaminejad, Mohamadreza, et al.
Publicado: (2011)

PM(2.5) Exposure-Linked Mitochondrial Dysfunction Negates SB216763-Mediated Cardio-Protection against Myocardial Ischemia–Reperfusion Injury
por: Sivakumar, Bhavana, et al.
Publicado: (2023)

Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches
por: Buonfiglio, Rosa, et al.
Publicado: (2020)

Hyperexcitability and Loss of Feedforward Inhibition Contribute to Aberrant Plasticity in the Fmr1KO Amygdala
por: Svalina, Matthew N., et al.
Publicado: (2021)

Lenticular mitoprotection. Part A: Monitoring mitochondrial depolarization with JC-1 and artifactual fluorescence by the glycogen synthase kinase-3β inhibitor, SB216763
por: Brooks, Morgan M., et al.
Publicado: (2013)

Molecular Insights Into Binding and Activation of the Human KCNQ2 Channel by Retigabine
por: Garofalo, Barbara, et al.
Publicado: (2022)

Metabolic Alterations in FMR1 Premutation Carriers
por: Cao, Yiqu, et al.
Publicado: (2020)

Improving Reproducibility to Enhance Scientific Rigor through Consideration of Mouse Diet
por: Westmark, Cara J., et al.
Publicado: (2022)

Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule
por: Hébert, Betty, et al.
Publicado: (2014)

A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons
por: Holley, Andrew J., et al.
Publicado: (2022)

In Vivo Volume Dynamics of Dendritic Spines in the Neocortex of Wild-Type and Fmr1 KO Mice
por: Ishii, Kazuhiko, et al.
Publicado: (2018)

Effect of AGG Interruptions on FMR1 Maternal Transmissions
por: Villate, Olatz, et al.
Publicado: (2020)

Diet in treatment of autism spectrum disorders
por: Alam, Sabiha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cq6p87j3eruc5rsc6ja81od7mh